Clinical trial · Observational
Genetic Basis of Hemangiomas
NCT00466375CI-TRIAL-00029331terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine if there are genes that are common in children with infantile hemangioma. This information will allow physicians to improve care for patients who have been diagnosed with this disease and to provide their parents with more complete information regarding the cause of this disease. This research is being done because many unanswered questions remain regarding children with infantile hemangioma. There are very few medications to treat infants with hemangiomas.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hemangioma, Vascular Anomalies | Hemangioma | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cheek cell sample or blood sample (4mL) | Genetic | — | UNRESOLVED |
| Cheek cell samples or blood sample (4mL) | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- A
- description
- Patients with a hemangioma.
- interventionNames
- Genetic: Cheek cell samples or blood sample (4mL)
- label
- B.
- description
- Patients with a vascular anomaly.
- interventionNames
- Genetic: Cheek cell sample or blood sample (4mL)
Primary outcomes (1)
- measure
- SNP
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Study Population Inclusion Criteria: * No limit to age * Diagnosis of infantile hemangioma and/or vascular anomaly * Unaffected twin sibling * Each patient's authorized legal guardian must understand the nature of the study and must provide written informed consent. Each patient must also give assent to study participation. Study Population Exclusion Criteria: * Diagnosis other than infantile hemangioma or vascular anomaly * If the lesion has resolved and cannot be confirmed as a hemangioma by clinical exam * If the biologic parents are unwilling or unable to submit DNA samples the child will be excluded from the DNA study. Therefore, if DNA samples cannot be or are not obtained from both biologic parents, the child and family will be excluded from the study.
References
Publications (0)
Data not yet available
No reference posted for this study.